tually leading to end-stage renal disease (ESRD) [1] [2] [3] [4] . Therefore, understanding the pathogenesis of interstitial fibrosis is crucial for developing therapeutic interventions for kidney diseases. However, the mechanism(s) of renal fibrogenesis are poorly understood.
Tubulointerstitial fibrosis is characterized by the loss of renal tubules and interstitial capillaries and the accumulation of matrix proteins. One of the most remarkable pathologic findings of interstitial fibrosis is the presence of myofibroblasts, which contain alpha-smooth muscle actin (a-SMA) in cytoplasm [5, 6] . In the normal kidney, interstitial myofibroblasts are rare. In contrast, myofibroblasts appear in markedly increased numbers in the fibrotic kidney predominantly within the fibrotic area. Myofibroblasts are morphologically intermediate between fibroblasts and smooth muscle cells. Like fibroblasts, myofibroblasts synthesize collagens I and III [7, 8] , while they retain a-SMA expression. Accumulating evidence in both experimental animals and humans has demonstrated correlation both between the presence of myofibroblasts and deterioration of renal function and with long-term prognosis [6, [9] [10] [11] [12] [13] . The role of myofibroblasts in the fibrogenic process was also supported by studies showing that once myofibroblasts become detectable in the interstitium, collagen deposition accumulates in the areas in which they reside [14, 15] .
The precise origin of myofibroblasts is of interest. Previously, these cells were thought to be derived from circulating bone marrow fibroblasts [16] . However, recent work utilizing chimeric animals showed that renal myofibroblasts were derived de novo from kidney cells [17] . Growing evidence now indicates that myofibroblasts transdifferentiate from tubular cells [i.e., undergoing epithelial to mesenchymal transformation (EMT)]. These then migrate to the interstitium [18] . Apart from tubular cells, a role for EMT is well established in many other types of epithelial cells and is associated with fibrogenesis and neovascularization [19, 20] . The mechanisms of renal tubular EMT are currently the focus of extensive investigations. In vitro data suggest that tubular EMT can be induced by profibrotic cytokines such as transforming growth factor (TGF-b1) [21, 22] , fibroblast growth factor (FGF) [23] , and interleukin-1 (IL-1) [24] . However, a role for hypoxia, which is a critical mediator of kidney disease progression [25] , in EMT remains to be elucidated.
According to their higher metabolic demands, proximal tubular cells (PTCs) are more susceptible to hypoxic stimuli [26] . Previous study showed that under hypoxic conditions proximal tubular cells dedifferentiate [27] . The expression of profibrotic factors such as collagen I, TGF-b1, and IL-1 also increases [28] . These changes appear to be mediated via both hypoxia inducible factor (HIF-1a)-dependent and independent pathways [29] .
We hypothesized that chronic hypoxia stimulates tubular-myofibroblast transdifferentiation, a crucial step in renal fibrosis. In this present study, we clarified the effect of chronic hypoxia on phenotypic and functional changes of tubular cells in vitro. Our in vivo study supported the role of hypoxia in tubular EMT as well. We also explored hypoxia-induced pathways that are involved in tubular EMT.
METHODS

Cell culture and hypoxic protocol
Immortalized rat proximal tubular cells (IRPTCs) were cultured in Dulbecco's modified Eagle's medium (DMEM) (Nissui Seiyaku, Tokyo, Japan) with 10% NaHCO 3 , 2 mmol/L HEPES, pH 7.5, and 5% fetal bovine serum (FBS) [30] . For immunohistochemical and motility assays, IRPTC were seeded in 4-or 8-well chamber slides (Lab Trek II, Nalgen Nunc, Naperville, IL, USA). For immunoblot analyses, IRPTCs were seeded in 6 cm culture dishes. After reaching 50% to 70% confluence, culture dishes were put in a hypoxic (1% O 2 , 5% CO 2, 37
• C) incubator (Astec Co., Fukuoka, Japan) for 3, 6, or 15 days; control dishes were incubated for equivalent periods under normoxic conditions (21% O 2 , 5% CO 2 , 37
• C). In order to preserve stable hypoxic conditions, the cells in the hypoxic group were periodically examined (every 3 days). The culture media were also changed every 3 days. Changing process was less than 3 minutes for each. In some experiments, cells were passaged if overconfluent. The average time for passaging cells was less than 8 minutes/dish. Each experiment was repeated three to eight times.
Cobaltous chloride (CoCl 2 )
Since most hypoxic stimuli are mediated via HIF-1a, we used CoCl 2 to stabilize HIF-1a without hypoxia. Ten, 30, or 60 lmol/L CoCl 2 was added to the culture media for 6-day experiments [31] .
Immunohistochemical analyses
At the end of the experiments, cells in 8-chamber slides were fixed with acetone and methanol 1:1 at −20
• C for 10 minutes. Direct immunoperoxidase staining was performed as previously described [32] . [33, 34] . The slides were then examined by light microscopy (Olympus BX51, Tokyo, Japan), and pictures were taken by Olympus DP12 system.
Quantitative immunohistochemical analysis
In this study, we observed two phenotypically distinct populations of a-SMA-positive cells. To explore the findings in more detail, we developed a simple classification. The first group was composed of elongated, spindleshaped hypertrophic cells, as compared to control tubular cells. These cells resemble fibroblasts that contain a-SMA rather than myofibroblasts. We defined these cells as a-SMA positive with fibroblast features (a-SMA + fib). The other group was composed of hypertrophic cells that were strongly positive for a-SMA with many projeted cytoplasmic borders, which is a typical characteristic of myofibroblasts [35] . Thus, we defined this group as a-SMA positive myofibroblasts (a-SMA + myo).
To compare the amount of a-SMA-positive cells in each experiment, cells were systematically counted in nonoverlapping fields, under 400× magnification, from the upper panel to the lower panel of the slide. The numbers of a-SMA + fib, a-SMA + myo, and total a-SMApositive cells per 1000 cells were measured for each experiment. This process was conducted in a blinded manner twice by the same observer within a 3-week-interval. The mean of these data was used for analysis. The numbers of cells positive for vimentin or desmin were also counted by the same methods per 1000 living cells.
Immunoblots analysis
Tubular cells were plated in 6 cm dishes and were treated with the same protocol as previously described.
At the end of the experiments, culture media were removed, and monolayer cells were washed twice with ice cold PBS, and then were detached with trypsin. Detached cells were collected, spun down at 4
• C, 1500 rpm for 5 minutes and washed twice with cold PBS. Cells were then incubated for 30 minutes with ice-cold radioimmunoprecipitation assay (RIPA) buffer [50 mmol/L TrisCl, 150 mmol/L NaCl, 1% Nonidet P-40, 0.5% sodium deoyl, 0.1% sodium dodecyl sulfate (SDS)] containing 10 mmol/L phenylmethylsulfonylfluoride (PMSF). Cells were expelled with force through a 23 G needle five times. The homogenized samples were centrifuged at 14,000 rpm for 15 minutes. The supernatants were collected, and protein content was determined with a detergentcompatible Bradford protein assay (BioRad, Hercules, CA, USA) according to the manufacturer's protocol [36] . For measurements of collagen I production, IRPTC and culture media were precipitated in 67% ethanol at 4
• C overnight [37] . The precipitated proteins were collected and dissolved in RIPA buffer. The lysates were stored at −20
• C until analysis. Equal amounts of protein were mixed with gel loading buffer under reducing conditions (0.25 mol/L Tris-HCl, 4% SDS, 10% sucrose, 0.004% bromphenol blue, 10% 2-mercaptoethanol). Samples were heated at 100
• C for 5 minutes and run in 8 or 12% SDS polyacrylamide gels, followed by electrotransfer to polyvinylidine difluoride (PVDF) membrane (Immobilon, Nihon Millipore, Yonezawa, Japan) or Hybond-ECL membrane (Amersham International, Buckingham, UK). The transferred membranes were blocked with 5% nonfat milk in Tris-buffered saline (TBS), 0.01% Tween-20 for 30 minutes at room temperature. The membranes were incubated with polyclonal goat antimouse type I collagen antibody (Southern Biotechnology, Burmingham, AL, USA) at 1:400 for 60 minute at room temperature, or with anti-SMA antibody overnight at 4
• C. After extensive wash in TBS, 0.01%Tween, the bound antibodies were detected with alkaline phosphatase-conjugated secondary antibodies. 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium tablets (Sigma Fast) (Sigma Chemical Co., St. Louis, MO, USA) were used as a substrate. In some experiments, the bound antibodies were detected by the enhanced chemiluminescence system, ECL (Amersham International).
Apoptosis and cell toxicity assay
Cell toxicity was evaluated by measuring absolute lactate dehydrogenase (LDH) concentrations (Sigma Diagnostics, St. Louis, MO, USA) in culture media at each change (every 3 days) [38] . The floating cells were counted by Trypan blue exclusion methods [37] . Apoptosis on a monolayer in each group was detected by in situ DNA fragmentation TACS blue label kit (Trevigen, Gaithersburg, MD, USA) according to the manufacturer's instruction as previous described [32] .
Cell motility assay
IRPTC (2 × 10 5 ) from the hypoxic group, the normoxic control group, and the CoCl 2 -treated group were seeded into 4-chamber slides containing the corresponding culture media. Twenty-four hours after passage, cells formed confluent monolayers. Cuts of 850 ± 43.2 micron width were made with a sterile scalpel. The cells were immediately washed with PBS to remove all the injured cells and cytokines. PBS was then replaced with new equivalent culture media, and the cells were incubated for 4 and 12 hours to allow migration [39] . This whole process was performed in less than 5 minutes. After 4 and 12 hours, cells were fixed with acetone and methanol as described above. These cells were stained with methyl green alone or with anti-aSMA and methyl green counterstaining in other experiments. The width of the scratch was measured with NIH imaging system, by selecting the three narrowest parts, at least 50 microns apart; the means of three narrowest distances were employed to calculate the motility distance for each experimental group.
Motility distance = 850 − scratch width microns 2
In vivo study: ischemic nephropathy
Six male Sprague-Dawley rats were subjected to induced ischemic nephropathy as previously described by Troung et al [40] . In brief, rats were general anesthetize with diethyl ether. After identification of the left renal artery, a 26 G needle was placed along the renal artery. Both artery and needle were ligated with silk twice 0.9 cm apart, and then the needle was removed. Twenty-fourhour urines were collected before the operation and at day 7 after the surgery. At day 7, the ischemic kidneys and contralateral kidneys were removed and overnight fixed in Methyl Carnoy's solution, followed by paraffin embedding. The rehydrated tissues were processed to stain periodic acid-Schiff (PAS) and a-SMA as described above.
Statistical analysis
All numerical data were presented in mean ± SD. Oneway analysis of variance (ANOVA) with post hoc analysis by least significant different (LSD) method (SPSS for Windows, version 10.0) was employed to determine the difference among the groups. The significant level was set at P < 0.05.
RESULTS
Chronic hypoxia-induced phenotypic changes in PTCs with de novo expression of a-SMA
Light microscopic examination showed that IRPTC assumed a cuboidal shape under normoxic conditions. These cells formed a cobblestone-like monolayer typical of tubular cells. Immunohistochemical staining for a-SMA, vimentin, and desmin were all negative under normoxic conditions (Fig. 1A) . These characteristics were stable for all cells cultured under normoxic conditions in this study.
After 3 days of hypoxia, some tubular cells expressed a-SMA in their cytoplasm, but morphologic changes were not detected (Fig. 1B) . a-SMA staining was more intense after 6 days of hypoxia, and significant morphologic changes were observed at this time point. Most of the a-SMA-positive cells were now elongated in shape and larger than control tubular cells cultured under normoxia, and were designated as a-SMA + fib (Fig. 1C) . For the longest period of hypoxia (15 days), phenotypic and morphologic changes were more easily observed (Fig. 1D) , with some cells larger than control tubular cells, demonstrating intense and filamentous expression of a-SMA with bifurcations in the cell borders, characteristic of myofibroblasts, and were designated as a-SMA + myo.
An increase in the number of a-SMA-positive cells appeared to be dependent on incubation time under hypoxia
Semiquantitative analysis revealed that expression of a-SMA and phenotypic changes in hypoxia increased in a 
Per 1000 cells P < 0.01 vs. normoxic control time-dependent manner (Fig. 2) . The number of a-SMApositive cells was significantly increased after incubation in hypoxia for 6 and 15 days (63.7 ± 18.29 and 92.69 ± 16.17 per 1000 cells, respectively), as compared to 3.33 ± 1.29 per 1000 cells (P < 0.001). The number of a-SMA + fib was significantly increased after 6 days of hypoxia (56 ± 14.36) and after 15 days of hypoxia (73.22 ± 15.63) as compared to that of the control group (3.06 ± 0.01) (P < 0.001). a-SMA + myo was significantly increased after 15 days of hypoxia.
Hypoxia failed to induce expression of vimentin or desmin in tubular cells
In addition to a-SMA, vimentin and desmin are mesenchymal markers of some subtypes of myofibroblasts (V-type, VD-type myofibroblast) [33] . Hypoxia failed to induce expression of desmin or vimentin in IRPTC (Fig. 3A and B) . The amount of desmin or vimentin did not differ between the hypoxic cells and equivalent controls (Fig. 3C) , suggesting that hypoxia per se did not induce expression of vimetin or desmin in IRPTC.
Immunoblots analysis confirmed an increase in a-SMA expression
We carried out the immunoblots analysis to confirm our immunohistochemical results. The expression of a-SMA in normoxic control was very little, while a-SMA was increased in a time dependent manner under hypoxic conditions, which was consistent with the immunohistochemical analysis (Fig. 4) . 
Production of collagen I was increased in hypoxic conditions
Collagen type I is a major component of extracellular matrix in fibrotic kidneys. Immunoblots analysis in the present study demonstrated increased production of collagen type I by IRPTC in hypoxic conditions. Production of collagen type I was observed in a time-dependent manner (Fig. 5) .
CoCl 2 increased a-SMA expression and collagen I synthesis
Immunohistochemical analysis showed that CoCl 2 induced expression of a-SMA in IRPTC in a dosedependent manner after a 6-day incubation period. Sixty micromol/liter of CoCl 2 was most effective in induction of a-SMA expression, whereas lower doses (10 lmol/L) of CoCl 2 demonstrated no effect. While CoCl 2 induced a-SMA expression, morphologic changes of the treated cells were not as dramatic as those incubated in hypoxia. Most a-SMA-positive cells were smaller than the control cells, and elongated in shape (Fig.6A) .
Our immunobloting analysis confirmed these findings. CoCl 2 also increased a-SMA expression in a dosedependent manner (Fig. 6B) . Cobalt induced synthesis of collagen type I as well (Fig. 5) . These results suggested regulation of these phenotypic changes via the HIF-1a-dependent pathway. 2 To confirm the role of hypoxia and a chemical mimicker, we identified HIF-1a by immunocytochemical methods. In normoxic conditions, HIF-1 a could not be detected. In contrast HIF-1a was markedly up-regulated in the hypoxic group predominately in the cell nucleus. Cells treated with CoCl 2 also showed an increase in expression of HIF-1a (Fig. 7) .
HIF-1a was increased by hypoxia or CoCl
Hypoxia increased cell migration of IRPTC
Migration is not a prominent feature of epithelial cells, including tubular cells. In contrast, interstitial mesenchymal cells, especially myofibroblasts, are motile under physiologic conditions. We tested the motility function to examine functional changes of IRPTC under hypoxic conditions. Four hours after placing a scratch on a monolayer, cells under hypoxic conditions migrated further as compared to normoxic controls. The means of migratory distances were 207.48 ± 92.15, 319.68 ± 52.32, and 386.38 ± 25.95 microns for normoxic, 6 days of hypoxia, and 15 days of hypoxia, respectively. The majority of the mobile cells that migrated to the edge of the migration contained a-SMA in their cytoplasm (Fig. 8) . For 12 hours study, the distance between the scratched cells was even less but significant in the normoxic group, while the scratches were completely covered with migrating cells and disappeared in both hypoxic groups (data not shown). Hypoxia of our condition did not increase apoptosis or significant cell cytotoxicity Supernatant LDH concentrations and Trypan blue exclusion assays in each media change did not differ between hypoxic and match normorxic control (data not shown). The excretory amount of LDH per total LDH in the normoxic control was 21.41% ± 0.79% while that of hypoxic were 22.36% ± 1.97%, 21.16% ± 0.82%, and 23.17% ± 1.65% for 3,6, and 15 day hypoxia, respectively ( Fig. 9G) . However, the excretory amount of LDH was increase to 25.42% + 0.71% in 6 days of 60 lmol/L cobalt group. In situ DNA fragment labeling assay showed that apoptosis did not increase. The number of apoptosis cells in control was 35.5 ± 6.1 per thousand cells. In hypoxic groups, the number of apoptosis cells was 23. ( Fig. 9A-D, F) . Cobalt increased cell apoptosis. The number of apoptosis cells in 6 day of 60 lmol/L cobalt increase to 102.2 ± 20.8 per thousand cells (P < 0.05 ANOVA). At any rate, the majority of cells remained survived ( Fig. 9E and F) . This data suggested the toxicity of chemical hypoxic mimicker and might explain the discrepancy of our finding between cobalt and hypoxic stimuli.
In vivo transdifferentiation of tubular cells was induced by chronic ischemia of the kidney
To support the role of hypoxia in transdifferrentiation, we induced chronic ischemic nephropathy in rats. Our data showed that severe tubulointerstitial damage rapidly developed as early as 1 week after induce ischemia (Fig. 10) . At this time point, the amount of urinary protein 
DISCUSSION
Accumulating evidence suggests that chronic hypoxia is involved in progressive kidney disease. Recent works have emphasized that the loss of peritubular capillary begins during the early period of renal disease, preceding the development of tubulointerstitial fibrosis and aggravating tubulointerstitial hypoxia. We previously showed that peritubular capillary loss occurred in a thrombotic microangiopathy model [41, 42] while others reported similar findings in remnant kidneys [43] , unilateral ureteral obstruction (UUO) [44] , and an anti-glomerular basement membrane (GBM) nephritis model [45] . In the present study, we demonstrated the transdifferentiation of tubular cells by hypoxia, as indicated by de novo expression of a mesenchymal marker, morphologic changes, and acquisition of mobility. Furthermore, we demonstrated in vivo EMT in a chronic ischemic model of the kidney. Taken together, our results supported the role of hypoxia in EMT, which is a crucial process in renal fibrogenesis [46] . We also propose that the mechanism of hypoxia-induced EMT may be, at least in part, regulated by the HIF-1a-dependent pathway.
Hypoxia has many effects on higher eukaryotic cells. Transcription of many genes is regulated by hypoxic stimuli via hypoxia-inducible factors, including vascular endothelial growth factor (VEGF), erythropoietin (EPO), glucose transporter (GLUT) and heme oxygenase-1 (HO-1) [47] . A variety of profibrotic cytokines are also up-regulated by hypoxia [37, 48, 49] . For long-term adaptation to hypoxia, cells reduce protein synthesis, turn off unnecessary membrane channels, and decrease cellular activities [27, 50] . Our work suggests unusual responses of tubular cells by changing their phenotypes. The number of a-SMA-positive cells began to increase after 3 days and reached a plateau in two weeks of hypoxia. The immunoblots data also supported these results. Morphologic changes appeared somewhat later. After 6 days of hypoxia, we observed characteristic myofibroblast-like morphology in a-SMA-positive cells. It is likely that expression of a-SMA and EMT may involve many genes and various steps of cell adaptation. The time course of EMT in our study is consistent with previous reports [21] . Yang and Liu [51] and Yang et al [52] previously showed that EMT needs many steps before completion of transdifferentiation. However, in this present study, hypoxia per se could not induce the expression of vimentin and desmin in our tubular cell line. These two antigens are expressed in some, but not all, myofibroblasts. Studies in liver and lung fibrosis showed that a-SMApositive vimentin-negative myofibroblasts participate in the pathogenesis of this process [8, 53] .
In addition to expression of new mesenchymal antigens, loss of normal cytoskeletal and cell-to-cell adhesion molecules is considered as a part of the EMT process [18, [21] [22] [23] . In the present study, we avoided testing the loss of these antigens because loss of normal structures by noxious stimuli such as hypoxia does not provide conclusive evidence of transformation. In contrast, hypoxic tubular cells gained motility function, generally not a feature of epithelial cells. Increased cell motility has been reported as one of the features of EMT [54, 55] . Since motility is an active and energy-consuming process, it is surprising that hypoxic cells treated for the longest period, which should lead to the most severe energy depletion, showed the highest motility. Furthermore, in our motility study, we found that most of the leading edge cells contained a-SMA in their cytoplasm. We also measured the amount of collagen I, a major component of the extracellular matrix, which accumulates in fibrotic tissues. Opharnides, Fine, and Norman [28] demonstrated increased collagen I synthesis by PTCs in hypoxic conditions. We confirmed and extended their findings, clarifying that amount of collagen I increased in a time-dependent manner and was strongly paralleled to EMT. We speculate that the transformed cells may take part in fibrogenesis via collagen I synthesis.
Cobaltous salt is well established as a chemical mimicker of hypoxia by stabilizing HIF1a [33, 37, 47] . In our study, a-SMA expression and collagen synthesis were induced by CoCl 2 in a dose-dependent manner. Immunohistochemical analysis of HIF-1a confirmed upregulation of HIF-1a in both hypoxic-and cobalt-treated groups. These results suggest that HIF-1a may also be involved in tubular EMT-induced by hypoxia. However, LDH assay and apoptosis study suggested that cobalt had additional cytotoxicity compared to hypoxia; therefore, not all aspects of EMT could be induced by cobalt (Table 1) In addition to the results of these in vitro studies, phenotypic changes of renal tubular cells were observed in many experimental models as well as in human diseases [18, [56] [57] [58] . It is possible that disruption of the tubular basement membrane, proteinuria, or infiltrative macrophages may play a role in in vivo transdifferentiation of tubular cells, the loss of peritubular capillaries and subsequent hypoxia in tubulointerstitial compartment in remnant kidneys may also be important [59] . Our in vivo experiments in chronic ischemic kidneys provided suggestive evidences that chronic ischemia/hypoxia might induce tubulointersitial fibrosis, as previously described [40] and tubular EMT. Since we did not observe significant proteinuria, this result strongly supported a role of hypoxia in EMT and progression of renal fibrosis.
CONCLUSION
Our work demonstrates an important role of hypoxia in tubular EMT, a crucial step in renal fibrosis and progression of kidney disease. This insight may lead to novel therapeutic interventions of chronic renal disease in the future.
